Good MorningEquity markets advanced on Tuesday, putting the S&P 500 at an all-time closing high. The move signals the market's willingness to continue the uptrend and may be a precursor to much higher price points. With earnings growth expected in 2025 and the potential for economic tailwinds to form by mid-year, the S&P 500 could sustain a rally through the end of 2025.
The stock rally is broadening. New highs in the Dow Jones Industrial Average, the Transportation Average, and the Russell 200 foreshadowed the move in the S&P. The move into other areas of the economy and small caps is a good sign but spells bad news for the previous market leaders. Names like NVIDIA, Amazon, Meta Platforms, and Microsoft may have difficulty setting new highs until sometime next year when sector rotation is completed. Featured: No. 1 way to leverage the “Trump bump” (Insiders Exposed) 
|
Markets | | |
Shares of Microsoft Corp (NASDAQ: MSFT) have been a cornerstone of tech portfolios for many years now, and 2024 has done little to tarnish that reputation. The stock is up a solid 15% year-to-date, and while it's struggled to push past July's all-time high, there are several reasons for investor... Read the Full Story |
|
From Our PartnersI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was.
Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. | | | | Here’s the full story for you. |
|
Markets | | | Two of London's most famous markets — one selling fish, the other meat — are set to close in the coming years, bringing an end to traditions stretching back to medieval times.On Wednesday, the City of London Corporation, the governing body in the capital city's historic hub, is set to present a bill... Read the Full Story |
|
Markets | | |
The Russell 2000 Index, often called the small-cap index, is up about 19.6% in 2024. Much of that gain has come in the last six months, and the clarity after the U.S. presidential election is stirring animal spirits in the sector.
The bull case for small-cap stocks comes from lower interest... Read the Full Story |
|
From Our PartnersJuan Villaverde called the top and bottom of every crypto bull market since 2012.
He believes Bitcoin will go to $150,000 — or more.
But there’s one coin he thinks could go even higher. | | | | This could be his favorite coin. |
|
Markets | | |
Donald Trump hasn't been shy about imposing tariffs when he returns to the White House in 2025. He has stated his intentions to levy 10% to 20% tariffs on imports and up to 60% to 100% tariffs on Chinese goods. Whether to take these statements literally or consider them negotiation tactics remains... Read the Full Story |
|
Markets | | |
Generic and biosimilar drugs are often preferred over the brand name version due to their cheaper prices. Generics are exact duplicates of the branded counterparts, while biosimilars are "similar" and often require clinical trials. Health insurance companies, Congress, and patients love generics. ... Read the Full Story |
|
From Our PartnersThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget!
We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months. | | | | 👉[Click here to get your FREE report delivered instantly!] |
|
Markets | | | Donald Trump loved to use tariffs on foreign goods during his first presidency. But their impact was barely noticeable in the overall economy, even if their aftershocks were clear in specific industries. The data show they never fully delivered on his promised factory jobs. Nor did they provoke the ... Read the Full Story |
|
Markets | | | Shares opened higher in Europe on Thursday after a mixed session in Asia following a Big Tech-led retreat on Wall Street. Germany's DAX advanced 0.7% to 19,394.41 while the CAC 40 in Paris gained 0.6% to 7,185.13. Britain's FTSE 100 rose 0.2% to 8,290.37. The futures for the S&P 500 and the Dow ... Read the Full Story |
|
Markets | | | South Korea’s central bank lowered its key policy rate for a second straight month and said the country’s economy will grow at a slower pace than it initially anticipated.Following a policy meeting, the Bank of Korea cut its benchmark interest rate by a quarter percentage point to 3%. The bank lower... Read the Full Story |
|
Markets | | |
The artificial intelligence (AI) revolution and cloud computing recovery are driving the worldwide growth of data centers. Existing data centers are furiously upgrading their systems to handle AI workloads, while new data centers are being built with AI deployment in mind. These AI data centers ar... Read the Full Story |
|
Markets | | | The number of Americans applying for unemployment benefits fell last week, remaining near seven-month lows.Jobless claim applications fell by 2,000 to 213,000 for the week of Nov. 23, the Labor Department reported Wednesday. The previous week’s level was revised up by 2,000 from 213,000, to 215,000.... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; Dovitinib, a pan- tyrosine kinase inhibitor for the treatment of renal cell carcinoma; IXEMPRA (ixabepilone), a selective microtubule inhibitor in phase 2 for the treatment of metastatic breast cancer; LiPlaCis, a liposomal formulation of cisplatin, which is in Phase 2 clinical trials for metastatic breast cancer; and 2X-111, a liposomal formulation of doxorubicin that is in Phase 2 clinical trials for metastatic breast cancer and glioblastoma multiforme. Allarity Therapeutics, Inc. has a collaboration with Detsamma Investments Pty. Ltd. to develop Deflexifol for the treatment of solid tumors. The company was incorporated in 2004 and is headquartered in Boston, Massachusetts. | | View Today's Stock Pick |
|
